Speciality pharmaceutical company Warner Chilcott plc (NASDAQ:WCRX) reported on Friday that it has completed its acquisition of the global branded prescription pharmaceutical business of consumer products group The Procter & Gamble Company (NYSE:PG).

Financial terms were not disclosed but Warner Chilcott said that it has used a combination of cash on hand and borrowings under new senior secured credit facilities to finance the purchase.

The deal includes approximately 1,900 employees of P&G's pharmaceutical business as well as manufacturing facilities in Germany and Puerto Rico.

Warner Chilcott said that this acquisition complements its existing women's health care portfolio and adds new therapeutic and geographic markets.